TB-500

TB-500 is a synthetic version of Thymosin Beta-4 (Tβ4), a naturally occurring 43-amino acid peptide conserved across species and expressed in various tissues. Research has shown that TB-500 interacts with actin, a protein crucial for cell migration and tissue remodeling. This interaction promotes actin polymerization, which is essential for angiogenesis and cell migration to injury sites.

Studies have demonstrated that TB-500 modulates the expression of genes involved in inflammation, wound healing, and tissue regeneration. For instance, it has been found to upregulate matrix metalloproteinases (MMPs), enzymes key to extracellular matrix remodeling and wound healing.

Research in mammalian models has revealed:

• Wound healing: TB-500 has been shown to enhance keratinocyte and fibroblast migration, stimulate angiogenesis, and reduce inflammation, contributing to faster healing in various wound types.
• Anti-inflammatory effects: Studies have demonstrated TB-500's ability to reduce pro-inflammatory cytokine production and increase anti-inflammatory cytokine levels in various inflammatory conditions.
• Hair growth stimulation: Research using mammalian models has found that TB-500 can increase hair follicle size and promote the transition from telogen to anagen phase.
• Neuroprotection: Studies have explored TB-500's potential to reduce neuroinflammation, oxidative stress, and apoptosis in models of neurological disorders.
• Cardioprotection: In mammalian models of myocardial infarction, TB-500 has been shown to reduce infarct size, improve cardiac function, and promote angiogenesis.

These TB-500 peptide benefits make it an important subject of ongoing research in tissue repair and cellular recovery.

While these findings are promising, it is important to note that TB-500 is currently a research tool, and its effects in mammals are still being studied.

• Injection site reactions (pain, redness, swelling)

• Headache

• Nausea

• Dizziness

• Fatigue

TB-500, a synthetic version of the naturally occurring peptide Thymosin Beta-4, has shown remarkable potential in various research settings. The peptide has been extensively studied for its ability to promote wound healing, reduce inflammation, stimulate hair growth, provide neuroprotection, and offer cardioprotection. TB-500 exerts its effects through multiple mechanisms, including its interaction with actin, modulation of gene expression, and regulation of inflammatory pathways.

As a research tool, TB-500 offers a valuable opportunity to explore the complex mechanisms underlying wound healing, inflammation, and tissue regeneration. The insights gained from these studies may pave the way for the development of novel therapeutic strategies for a wide range of conditions, from skin wounds and hair loss disorders to neurodegenerative diseases and cardiovascular disorders.

1. Bock-Marquette I, Maar K, Maar S, Lippai B, Faskerti G, Gallyas F Jr, Olson EN, Srivastava D. Thymosin beta-4 denotes new directions towards developing prosperous anti-aging regenerative therapies. Int Immunopharmacol. 2023 Mar;116:109741. doi: 10.1016/j.intimp.2023.109741. Epub 2023 Jan 27. PMID: 36709593.

2. Belsky JB, Rivers EP, Filbin MR, Lee PJ, Morris DC. Thymosin beta 4 regulation of actin in sepsis. Expert Opin Biol Ther. 2018 Jul;18(sup1):193-197. doi: 10.1080/14712598.2018.1448381. Epub 2018 Mar 6. PMID: 29508629; PMCID: PMC6556887.

3. Bubb MR. Thymosin beta 4 interactions. Vitam Horm. 2003;66:297-316. doi: 10.1016/s0083-6729(03)01008-2. PMID: 12852258.

4. Sosne G. Thymosin beta 4 and the eye: the journey from bench to bedside. Expert Opin Biol Ther. 2018 Jul;18(sup1):99-104. doi: 10.1080/14712598.2018.1486818. PMID: 30063853.

5. Pipes GT, Yang J. Cardioprotection by Thymosin Beta 4. Vitam Horm. 2016;102:209-26. doi: 10.1016/bs.vh.2016.04.004. Epub 2016 May 31. PMID: 27450736.

6. Song K, Han HJ, Kim S, Kwon J. Thymosin beta 4 attenuates PrP(106-126)-induced human brain endothelial cells dysfunction. Eur J Pharmacol. 2020 Feb 15;869:172891. doi: 10.1016/j.ejphar.2019.172891. Epub 2019 Dec 23. PMID: 31877278.

7. Choi J, Cho Y, Choi H, Lee S, Han H, Lee J, Kwon J. Thymosin Beta 4 Inhibits LPS and ATP-Induced Hepatic Stellate Cells via the Regulation of Multiple Signaling Pathways. Int J Mol Sci. 2023 Feb 8;24(4):3439. doi: 10.3390/ijms24043439. PMID: 36834849; PMCID: PMC9959661.

8. Kim J, Jung Y. Thymosin Beta 4 Is a Potential Regulator of Hepatic Stellate Cells. Vitam Horm. 2016;102:121-49. doi: 10.1016/bs.vh.2016.04.011. Epub 2016 May 31. PMID: 27450733.

9. Han HJ, Kim S, Kwon J. Thymosin beta 4-Induced Autophagy Increases Cholinergic Signaling in PrP (106-126)-Treated HT22 Cells. Neurotox Res. 2019 Jul;36(1):58-65. doi: 10.1007/s12640-018-9985-0. Epub 2018 Dec 15. PMID: 30552633.

10. Kim J, Jung Y. Potential role of thymosin Beta 4 in liver fibrosis. Int J Mol Sci. 2015 May 8;16(5):10624-35. doi: 10.3390/ijms160510624. PMID: 26006229; PMCID: PMC4463665.